apx3330
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 30, 2018 (NCT03375086)
Timeline
Indications
Mechanism of action
APEX1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04692688 | Phase 2 | Jan 14, 2021 | Ocuphire Pharma, Inc. |
| NCT03375086 | Phase 1 | Jan 30, 2018 | Apexian Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Apexian Pharmaceuticals, Inc. | For profit | 1 | 1 | 1 | 2018 |
| Ocuphire Pharma, Inc. | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1